Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 106903
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.106903
Table 2 Comparison of general data, mean ± SD/n (%)
Items
Infected group (n = 41)
Non-infected group (n = 171)
t/χ2 value
P value
Age (years old)≥ 7027 (65.85)76 (44.44)4.7670.029
60-6914 (34.15)95 (55.55)
Sex (cases)Male24 (58.54)112 (65.50)0.6970.404
Female17 (41.46)59 (34.50)
Body mass index (kg/m2)25.42 ± 2.1324.79 ± 2.091.5470.123
Smoking historyWith23 (56.10)101 (59.06)0.1200.729
Without18 (43.90)70 (40.94)
Drinking historyWith22 (53.66)79 (46.20)0.7380.390
Without19 (46.34)92 (53.80)
HypertensionWith27 (65.85)94 (54.97)1.5990.206
Without14 (34.15)77 (45.03)
HyperlipidemiaWith14 (34.15)82 (47.95)2.5440.111
Without27 (65.85)89 (52.05)
Respiratory diseasesWith25 (60.98)71 (41.52)5.0520.026
Without16 (39.02)100 (58.48)
TNM stageI stage16 (39.02)98 (57.31)4.4480.035
II-III stage25 (60.98)73 (42.69)
Maximum diameter of tumor≥ 4 cm22 (53.66)60 (35.09)4.8090.028
< 4 cm19 (46.34)111 (64.91)
Neoadjuvant chemotherapy≥ 2 times27 (65.85)64 (37.43)10.908< 0.001
< 2 times14 (34.15)107 (62.57)
Pathological typeSquamous carcinoma22 (53.66)111 (64.91)1.7920.181
Adenocarcinoma19 (46.34)60 (35.09)